Presentation is loading. Please wait.

Presentation is loading. Please wait.

When is HIT Really HIT? The Annals of Thoracic Surgery

Published byPierce Martin Modified over 5 years ago

Similar presentations

Presentation on theme: "When is HIT Really HIT? The Annals of Thoracic Surgery"— Presentation transcript:

1 When is HIT Really HIT? The Annals of Thoracic Surgery
Theodore E. Warkentin, MD, Mark A. Crowther, MD  The Annals of Thoracic Surgery  Volume 83, Issue 1, Pages (January 2007) DOI: /j.athoracsur Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Iceberg model of heparin-induced thrombocytopenia (HIT). One implication of this model is that there are considerable differences in diagnostic specificity among various laboratory assays to detect HIT antibodies, with the highest specificity seen with the washed platelet activation assays (eg, serotonin-release assay [SRA], heparin-induced platelet activation assay) compared with the PF4/heparin (PF4/H) enzyme-immunoassays (EIAs). The rapid assay, the particle gel immunoassay (PaGIA), appears to have intermediate specificity. Thus, there is the potential to overdiagnose HIT, especially when using relatively nonspecific assays, and when testing a patient population with a high frequency of forming nonpathological antibodies, and with a high frequency of non-HIT explanations for thrombocytopenia. These considerations apply to a ventricular assist device (VAD) population. (IgA = immunoglobulin A; IgG = immunoglobulin G; IgM = immunoglobulin M.) The Annals of Thoracic Surgery  , 21-23DOI: ( /j.athoracsur ) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Three thrombocytopenic ventricular assist device (VAD) patients. Although all patients have thrombocytopenia and at least two positive tests for anti-PF4/heparin antibodies, the probability that any given patient actually has heparin-induced thrombocytopenia (HIT) differs considerably, ranging from (A) not HIT, to (B) probable HIT, to (C) unlikely HIT. (See also text for further comments.) (+ = positive test; − = negative test; PaGIA = particle gel immunoassay; PF4/H-EIA = PF4/heparin (or PF4/polyanion) enzyme-immunoassay; SRA = serotonin-release assay; VAD = ventricular assist device.) The Annals of Thoracic Surgery  , 21-23DOI: ( /j.athoracsur ) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "When is HIT Really HIT? The Annals of Thoracic Surgery"

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.
Elvira Maličev Blood Transfusion Centre of Slovenia

Elvira Maličev Blood Transfusion Centre of Slovenia
Ventricular Assist Device Driveline Infection: Treatment With Platelet-Rich Plasma  Federica Jiritano, MD, Giuseppe Filiberto Serraino, MD, Michele Rossi,

Ventricular Assist Device Driveline Infection: Treatment With Platelet-Rich Plasma  Federica Jiritano, MD, Giuseppe Filiberto Serraino, MD, Michele Rossi,
Giant Transdiaphragmatic Intercostal Hernia

Giant Transdiaphragmatic Intercostal Hernia
Pulmonary Lobectomy in a Patient With a Left Ventricular Assist Device

Pulmonary Lobectomy in a Patient With a Left Ventricular Assist Device
The STS National Database

The STS National Database
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 
Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,
The particle gel immunoassay as a rapid test to rule out heparin-induced thrombocytopenia?  Katharina Schallmoser, MD, Camilla Drexler, MD, Eva Rohde,

The particle gel immunoassay as a rapid test to rule out heparin-induced thrombocytopenia?  Katharina Schallmoser, MD, Camilla Drexler, MD, Eva Rohde,
Theodore E. Warkentin, MD  The American Journal of Medicine 

Theodore E. Warkentin, MD  The American Journal of Medicine 
Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support  Soren Schenk, MD, Aly El-Banayosy, MD, Wolfgang Prohaska, MD, Latif.

Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support  Soren Schenk, MD, Aly El-Banayosy, MD, Wolfgang Prohaska, MD, Latif.
Heparin-Induced Thrombocytopenia in Patients with Ventricular Assist Devices: Are New Prevention Strategies Required?  Theodore E. Warkentin, MD, Andreas.

Heparin-Induced Thrombocytopenia in Patients with Ventricular Assist Devices: Are New Prevention Strategies Required?  Theodore E. Warkentin, MD, Andreas.
Diaphragmatic Defect Complicating Peritoneal Dialysis

Diaphragmatic Defect Complicating Peritoneal Dialysis
Dhaval Chauhan, MD, Alexis K

Dhaval Chauhan, MD, Alexis K
A New Endoluminal Resection Technique and Device: Resector Balloon

A New Endoluminal Resection Technique and Device: Resector Balloon
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Bi-Ventricular Circulatory Support With the Abiomed AB5000 System in a Patient With Idiopathic Refractory Ventricular Fibrillation  Li Zhang, MD, MS,

Bi-Ventricular Circulatory Support With the Abiomed AB5000 System in a Patient With Idiopathic Refractory Ventricular Fibrillation  Li Zhang, MD, MS,
Long Esophageal Segment Laceration Caused by an Orogastric Tube During Laparoscopic Sleeve Gastrectomy  Sang Kuon Lee, MD, Jongho Lee, MD  The Annals.

Long Esophageal Segment Laceration Caused by an Orogastric Tube During Laparoscopic Sleeve Gastrectomy  Sang Kuon Lee, MD, Jongho Lee, MD  The Annals.
Jacob N. Schroder, MD, Mani A. Daneshmand, MD, Nestor R

Jacob N. Schroder, MD, Mani A. Daneshmand, MD, Nestor R
Prevalence of Heparin/Platelet Factor 4 Antibodies Before and After Cardiac Surgery  Brendan M. Everett, MD, Robert Yeh, MD, Shi Yin Foo, MD, PhD, David.

Prevalence of Heparin/Platelet Factor 4 Antibodies Before and After Cardiac Surgery  Brendan M. Everett, MD, Robert Yeh, MD, Shi Yin Foo, MD, PhD, David.

Similar presentations

Ads by Google